Equal-WT
WhaleScore 2.0
?
Altium Capital Management is based out of New York. Their last reported 13F filing for Q2 2024 included $245,120,808 in managed 13F securities
and a top 10 holdings concentration of 55.89%. Altium Capital Management's largest holding is Vera Therapeutics Inc with shares held of 714,000. Whalewisdom has at least 17 13F filings, and 162 13G filings
2024-06-30
Top Buys (13F)
Name | % Change |
---|---|
SRPT Sarepta Therapeutics | 5.28% |
SKYE Skye Bioscience Inc | 4.41% |
ARGX Argenx SE ADS ADR | 4.04% |
INSM Insmed Inc | 3.9% |
CTNM Contineum Therapeuti | 3.08% |
2024-06-30
Top Sells (13F)
Name | % Change |
---|---|
VKTX Viking Therapeutics (PUT) | 5.69% |
HDGE AdvisorShares Ranger (CALL) | 4.46% |
BHVN Biohaven Ltd | 3.03% |
AXSM Axsome Therapeutics | 2.72% |
OLMA Olema Pharmaceutical | 2.71% |
2024-06-30
13F Holdings Summary
Name | $ Change |
---|---|
VERA Vera Therapeutics In | 10.54% |
ADMA ADMA Biologics Inc | 6.89% |
XENE Xenon Pharmaceutical | 5.74% |
ITCI Intra-Cellular Thera | 5.39% |
SRPT Sarepta Therapeutics | 5.28% |
2024-06-30
13F Activity
Market Value | $245m, Prior: $253m |
Inflows (Outflows) as % of Total MV | +2.9286% |
New Purchases | 18 stocks |
Added To | 14 stocks |
Sold out of | 22 stocks |
Reduced holdings in | 12 stocks |
Top 10 Holdings % | 55.89% |
Turnover %[1] | 44.44% |
Turnover Alt %[2] | 35.84% |
Time Held Top 20 | 1.5 quarters |
Time Held Top 10 | 0.8 quarters |
Time Held All | 3.32 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2024-06-30
13F Sector Allocation Over Time
limited to past 4 quarters. Subscribe to see all available data
2024-06-30
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2024-06-30